Collateral metabolic vulnerabilities unveiled by loss of isozyme diversity in breast cancer

Rui Ding, Tian-Jian Yu, Yi-Zhou Jiang, Yi Xiao, Zhi-Ming Shao · 2025

Read Collateral metabolic vulnerabilities unveiled by loss of isozyme diversity in breast cancer by Rui Ding, Tian-Jian Yu, Yi-Zhou Jiang, Yi Xiao, Zhi-Ming Shao (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12817777.txt.

Description

Rui Ding and colleagues mapped a metabolic weakness in breast cancer in 2025. Cancer cells often keep backup enzyme versions. Losing backup versions creates single-enzyme dependence. That dependence can become a drug target. Large breast cancer datasets were integrated.

Patterns covered all breast cancer subtypes. One clear weakness involved a transferase enzyme. Blocking its partner enzyme hurt those tumours. The effect may run through a growth protein. That protein needs a fat modification step. Inhibitor drugs already exist for testing. The authors frame a precision strategy. Multi-omics data made the mapping possible.

Catalog record

CREATORRui Ding, Tian-Jian Yu, Yi-Zhou Jiang, Yi Xiao, Zhi-Ming Shao
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE78 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12817777

Browse the full library · About the Tower of Babel